Ohlsson A - Search Results

1

Single dose kinetics of deuterium labelled delta 1-tetrahydrocannabinol in heavy and light cannabis users.

Ohlsson A, Lindgren JE, Wahlén A, Agurell S, Hollister LE, Gillespie HK. Ohlsson A, et al. Biomed Mass Spectrom. 1982 Jan;9(1):6-10. doi: 10.1002/bms.1200090103. Biomed Mass Spectrom. 1982. PMID: 6277407

2

Single-dose kinetics of deuterium-labelled cannabidiol in man after smoking and intravenous administration.

Ohlsson A, Lindgren JE, Andersson S, Agurell S, Gillespie H, Hollister LE. Ohlsson A, et al. Biomed Environ Mass Spectrom. 1986 Feb;13(2):77-83. doi: 10.1002/bms.1200130206. Biomed Environ Mass Spectrom. 1986. PMID: 2937482

3

Single-dose kinetics of deuterium-labelled cannabinol in man after intravenous administration and smoking.

Johansson E, Ohlsson A, Lindgren JE, Agurell S, Gillespie H, Hollister LE. Johansson E, et al. Among authors: ohlsson a. Biomed Environ Mass Spectrom. 1987 Sep;14(9):495-9. doi: 10.1002/bms.1200140904. Biomed Environ Mass Spectrom. 1987. PMID: 2960395

4

Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.

Lindgren JE, Ohlsson A, Agurell S, Hollister L, Gillespie H. Lindgren JE, et al. Among authors: ohlsson a. Psychopharmacology (Berl). 1981;74(3):208-12. doi: 10.1007/BF00427095. Psychopharmacology (Berl). 1981. PMID: 6267648 Clinical Trial.

5

Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man.

Agurell S, Halldin M, Lindgren JE, Ohlsson A, Widman M, Gillespie H, Hollister L. Agurell S, et al. Among authors: ohlsson a. Pharmacol Rev. 1986 Mar;38(1):21-43. Pharmacol Rev. 1986. PMID: 3012605 Review. No abstract available.

6

Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking.

Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Ohlsson A, et al. Clin Pharmacol Ther. 1980 Sep;28(3):409-16. doi: 10.1038/clpt.1980.181. Clin Pharmacol Ther. 1980. PMID: 6250760

7

Plasma levels of delta 9-tetrahydrocannabinol after intravenous, oral, and smoke administration.

Ohlsson A, Lindgren JE, Wahlen A, Agurell S, Hollister LE, Gillespie HK. Ohlsson A, et al. NIDA Res Monogr. 1981 Feb;34:250-6. NIDA Res Monogr. 1981. PMID: 6261133 No abstract available.

8

Do plasma concentrations of delta 9-tetrahydrocannabinol reflect the degree of intoxication?

Hollister LE, Gillespie HK, Ohlsson A, Lindgren JE, Wahlen A, Agurell S. Hollister LE, et al. Among authors: ohlsson a. J Clin Pharmacol. 1981 Aug-Sep;21(S1):171S-177S. doi: 10.1002/j.1552-4604.1981.tb02593.x. J Clin Pharmacol. 1981. PMID: 6271822

9

Interactions of delta 1-tetrahydrocannabinol with cannabinol and cannabidiol following oral administration in man. Assay of cannabinol and cannabidiol by mass fragmentography.

Agurell S, Carlsson S, Lindgren JE, Ohlsson A, Gillespie H, Hollister L. Agurell S, et al. Among authors: ohlsson a. Experientia. 1981 Oct 15;37(10):1090-2. doi: 10.1007/BF02085029. Experientia. 1981. PMID: 6273208 No abstract available.

10

Introduction to quantification of cannabinoids and their metabolites in biological fluids.

Agurell S, Lindgren JE, Ohlsson A. Agurell S, et al. Among authors: ohlsson a. Adv Biosci. 1978 Jul 22-23;22-23:3-13. doi: 10.1016/b978-0-08-023759-6.50006-8. Adv Biosci. 1978. PMID: 756831 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

492 results

Search Page

Filters